This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David Orain - Innovator in Pharmaceutical Research
Introduction
David Orain is an accomplished inventor based in Basel, Switzerland. He is currently associated with Novartis AG, a leading global healthcare company. Although he does not hold any granted patents, his contributions to pharmaceutical research are noteworthy.
Latest Patent Applications
David Orain has been involved in several significant patent applications. One of his latest applications is titled "Use of 1H-Quinazoline-2,4-Diones." This invention concerns the use of competitive AMPA receptor antagonists for the treatment, prevention, or delay of progression of Rasmussen's encephalitis and/or certain forms of epilepsy. Another application is for "Benzamides Useful as S1P Receptor Modulators." This invention relates to novel aromatic compounds, which can be used as medicaments and includes their preparation and formulation.
Conclusion
David Orain's work at Novartis AG highlights his commitment to advancing medical science through innovative research. His latest patent applications reflect his dedication to addressing complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile